DB15847InvestigationalVaccines
BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and... The components of the vaccine include BBV152A, BBV152B, and BBV152C.
- Also known as
- Covaxin · Whole-Virion Inactivated SARS-CoV-2 Vaccine
- Code names
- BBV152
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of BBV152, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account